Epidemiological Evidence Workbench

Vaccine Safety Evidence & Adverse Event Signal Analyzer

Context: @axios reporting on vaccine safety claims · Biostatistical Verification
Objective Evidence Synthesis: Evaluating unverified spontaneous reporting (VAERS) against controlled peer-reviewed cohort studies across 10M+ patient-years.
Methodology: GRADE & Cochrane Risk of Bias

Signal Selection & Filters

Observed Relative Risk (RR) 1.02
1.0 = Exact null effect / no increased risk
95% CI Lower Bound 0.95
95% CI Upper Bound 1.09
Total Sample Size (N) 1,250,000
Peer-Reviewed Controlled Studies 42
VAERS / Spontaneous Reports 1,420

Signal Verification Metrics Validated Safe

Signal Strength Score
1.4
0.0 (Null) - 10.0 (High)
Statistical Significance
Not Significant (Null Effect)
p = 0.62 (95% CI includes 1.0)
Risk of Bias Rating
Low (Large-Scale Controlled Studies)
GRADE Methodology
Consensus Status
Overwhelming Epidemiological Consensus
Global Health Bodies

D3.js Evidence Matrix: Sample Size vs Relative Risk (with 95% CI)

Side-by-Side Signal Ledger: Claim vs Empirical Cohort

Evidence Dimension Spontaneous Unverified Claims Controlled Peer-Reviewed Studies Statistical Variance
Cohort Scale 1,420 unverified event submissions 1,250,000 verified patients across 42 trials 880x higher statistical power
Relative Risk (RR) Uncontrolled temporal association 1.02 (95% CI: 0.95 - 1.09) Null difference from unexposed cohort
Confounding Control Zero adjustment for baseline age/health Multivariable propensity score matching Eliminates reporting & selection bias
Diagnostic Verification Self-reported or unconfirmed notes Independent clinical chart adjudication Gold-standard phenotypic validation
Audited Verification Result: Current biostatistical evaluation confirms MMR Vaccine & Autistic Spectrum Disorder Risk holds a relative risk ratio of 1.02 over 1,250,000 subjects, validating safety and rejecting causal association.
Epidemiological Sources & Literature Foundations:
  • Madsen KM, et al. A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism. N Engl J Med. 2002. (Sample: 537,303 children).
  • Hviid A, et al. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. Ann Intern Med. 2019. (Sample: 657,461 children).
  • CDC / FDA Vaccine Adverse Event Reporting System (VAERS) User Guide: Spontaneous reports represent temporal associations, not causality.
Enjoy this tool? Build your own with Super